Ever Source Wealth Advisors, LLC Pds Biotechnology Corp Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 431 shares of PDSB stock, worth $577. This represents 0.0% of its overall portfolio holdings.
Number of Shares
431
Previous 169
155.03%
Holding current value
$577
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
59Shares Held
4.22MCall Options Held
170KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.02 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$652,5350.0% of portfolio
-
Geode Capital Management, LLC Boston, MA417KShares$559,0700.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA247KShares$330,9490.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il220KShares$295,0880.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $38.1M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...